Allakos Net Margin

The Net Margin of Allakos Inc (ALLK) is N/A.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

Allakos Net Margin - Peers Comparison

Ticker	Name	Value
INSM	Insmed Inc	-251.24%
MYGN	Myriad Genetics Inc	-15.20%
NBIX	Neurocrine Biosciences Inc	14.49%
950160.KQ	Kolon TissueGene Inc	-666.19%
BBIO	BridgeBio Pharma Inc	-241.44%
MDGL	Madrigal Pharmaceuticals Inc	-258.64%
PTCT	PTC Therapeutics Inc	-45.03%
VIR	Vir Biotechnology Inc	-703.40%
VRTX	Vertex Pharmaceuticals Inc	-4.86%
950200.KQ	Psomagen Inc	-13.29%
ARWR	Arrowhead Pharmaceuticals Inc	-16882.37%
GILD	Gilead Sciences Inc	1.67%
MGNX	MacroGenics Inc	-44.66%
SRRK	Scholar Rock Holding Corp	-405.24%
EDIT	Editas Medicine Inc	-733.72%
MRNA	Moderna Inc	-110.04%
PGEN	Precigen Inc	-3216.18%
TVTX	Travere Therapeutics Inc	-137.90%
VCEL	Vericel Corp	4.37%
ZNTL	Zentalis Pharmaceuticals Inc	-245.96%
ACAD	ACADIA Pharmaceuticals Inc	23.64%
AGIO	Agios Pharmaceuticals Inc	1845.92%
MORF	Morphic Holding Inc	-29192.90%
ORGO	Organogenesis Holdings Inc	0.18%
AMRN	Amarin Corporation PLC	-35.95%
BCRX	BioCryst Pharmaceuticals Inc	-19.72%
EXEL	Exelixis Inc	24.04%
HRTX	Heron Therapeutics Inc	-9.41%
AMGN	Amgen Inc	12.24%
NTRA	Natera Inc	-11.22%
REGN	Regeneron Pharmaceuticals Inc	31.07%
TWST	Twist Bioscience Corp	-66.69%
XNCR	Xencor Inc	-210.53%
ABBV	Abbvie Inc	7.59%
CBPO	China Biologic Products Holdings Inc	29.04%
SRNE	Sorrento Therapeutics Inc	-912.10%